Postischemic microvasculopathy and endothelial progenitor cell-based therapy in ischemic AKI: update and perspectives

被引:17
|
作者
Patschan, D. [1 ]
Kribben, A. [2 ]
Mueller, G. A. [1 ]
机构
[1] Univ Gottingen, Univ Hosp Gottingen, Clin Nephrol & Rheumatol, Gottingen, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany
关键词
acute kidney injury; EPCs; microvasculopathy; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; MESENCHYMAL STEM-CELLS; CISPLATIN-INDUCED NEPHROTOXICITY; REPERFUSION INJURY; MITOCHONDRIAL INJURY; BARRIER FUNCTION; PROXIMAL TUBULE; POTENTIAL ROLE; RAT MODEL;
D O I
10.1152/ajprenal.00232.2016
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Acute kidney injury (AKI) dramatically increases mortality of hospitalized patients. Incidences have been increased in recent years. The most frequent cause is transient renal hypoperfusion or ischemia which induces significant tubular cell dysfunction/damage. In addition, two further events take place: interstitial inflammation and microvasculopathy (MV). The latter evolves within minutes to hours postischemia and may result in permanent deterioration of the peritubular capillary network, ultimately increasing the risk for chronic kidney disease (CKD) in the long term. In recent years, our understanding of the molecular/cellular processes responsible for acute and sustained microvasculopathy has increasingly been expanded. The methodical approaches for visualizing impaired peritubular blood flow and increased vascular permeability have been optimized, even allowing the depiction of tissue abnormalities in a three-dimensional manner. In addition, endothelial dysfunction, a hallmark of MV, has increasingly been recognized as an inductor of both vascular malfunction and interstitial inflammation. In this regard, so-called regulated necrosis of the endothelium could potentially play a role in postischemic inflammation. Endothelial progenitor cells (EPCs), represented by at least two major subpopulations, have been shown to promote vascular repair in experimental AKI, not only in the short but also in the long term. The discussion about the true biology of the cells continues. It has been proposed that early EPCs are most likely myelomonocytic in nature, and thus they may simply be termed proangiogenic cells (PACs). Nevertheless, they reliably protect certain types of tissues/organs from ischemia-induced damage, mostly by modulating the perivascular microenvironment in an indirect manner. The aim of the present review is to summarize the current knowledge on postischemic MV and EPC-mediated renal repair.
引用
收藏
页码:F382 / F394
页数:13
相关论文
共 50 条
  • [21] Ischemic preconditioning for cell-based therapy and tissue engineering
    Hsiao, Sarah T.
    Dilley, Rodney J.
    Dusting, Gregory J.
    Lim, Shiang Y.
    PHARMACOLOGY & THERAPEUTICS, 2014, 142 (02) : 141 - 153
  • [22] Proangiogenic cell-based therapy for treatment of ischemic diseases
    Silvestre, Jean-Sebastien
    M S-MEDECINE SCIENCES, 2009, 25 (11): : 931 - 937
  • [23] Neural Stem Cell-Based Therapy for Ischemic Stroke
    Kokaia, Zaal
    Darsalia, Vladimer
    TRANSLATIONAL STROKE RESEARCH, 2011, 2 (03) : 272 - 278
  • [24] Mesenchymal stem cell-based therapy for ischemic stroke
    Anderson J.D.
    Pham M.T.
    Contreras Z.
    Hoon M.
    Fink K.D.
    Johansson H.J.
    Rossignol J.
    Dunbar G.L.
    Showalter M.
    Fiehn O.
    Bramlett C.S.
    Bardini R.L.
    Bauer G.
    Fury B.
    Hendrix K.J.
    Chedin F.
    El-Andaloussi S.
    Hwang B.
    Mulligan M.S.
    Lehtiö J.
    Nolta J.A.
    Chinese Neurosurgical Journal, 2 (1)
  • [25] Neural Stem Cell-Based Therapy for Ischemic Stroke
    Zaal Kokaia
    Vladimer Darsalia
    Translational Stroke Research, 2011, 2 : 272 - 278
  • [26] Stem Cell-Based Therapy for Ischemic Heart Disease
    Hsiao, Lien-Cheng
    Carr, Carolyn
    Chang, Kuan-Cheng
    Lin, Shinn-Zong
    Clarke, Kieran
    CELL TRANSPLANTATION, 2013, 22 (04) : 663 - 675
  • [27] Potential of Stem Cell-Based Therapy for Ischemic Stroke
    Marei, Hany E.
    Hasan, A.
    Rizzi, R.
    Althani, A.
    Afifi, N.
    Cenciarelli, C.
    Caceci, Thomas
    Shuaib, Ashfaq
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [28] Adult stem cell-based therapy for ischemic stroke
    Verfaillie, Catherine M.
    NEUROREPORT, 2014, 25 (03) : 150 - 151
  • [29] Biomimetic material systems for neural progenitor cell-based therapy
    Potter, Wyatt
    Kalil, Ronald E.
    Kao, Weiyuan J.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 806 - 821
  • [30] Progress of stem/progenitor cell-based therapy for retinal degeneration
    Tang, Zhimin
    Zhang, Yi
    Wang, Yuyao
    Zhang, Dandan
    Shen, Bingqiao
    Luo, Min
    Gu, Ping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15